PDA explores the transformation of healthcare at 4th Annual European Meeting
Posted: 11 June 2019 | Parenteral Drug Association | No comments yet
The Parenteral Drug Association (PDA) is excited to host its 4th Annual European Meeting.
Bethesda, Md. – The Parenteral Drug Association (PDA) is excited to host its 4th Annual European Meeting: Global Healthcare of the Present and the Future, June 25-26 in Amsterdam, The Netherlands, the new location of the European Medicines Agency, where industry and regulatory agencies will present their perspectives on the transformation unfolding in the pharmaceutical sector regarding the digitalization and automation of manufacturing processes.
From the Max Planck Institute for Human Development, Felix G. Rebitschek will deliver the keynote speech, “Decision-Making Under Uncertainty.” Following him, the opening plenary “Regulatory Updates – Current Situation” will discuss understanding regulatory frameworks in an atmosphere of rapid change and provide the opportunity to participate in conversation with regulators and industry representatives.
Regulatory agencies sharing industry updates include the European Medicines Agency, U.S. FDA, WHO, MHRA and HPRA, PIC/S.
A series of parallel tracks will offer the chance to learn about topics ranging from virtual reality, data quality management, manufacturing technologies and much more.
Learn more about the topics that will be examined in-depth on our website.
Registration can be completed until June 24.
Members of the press are welcome to apply for a press pass here.
To learn more about PDA, click here.
European Medicines Agency., fda, HPRA, Max Planck Institute for Human Development, MHRA, Parenteral Drug Association, PIC/S, WHO